April 9, 2018 / 9:29 PM / 5 months ago

BRIEF-PDL Biopharma Shareholder, Sevensaoi Capital, Comments On The Nomination Of Shlomo Yanai To PDL Board

April 9 (Reuters) - PDL BioPharma Inc:

* PDL BIOPHARMA SHAREHOLDER, SEVENSAOI CAPITAL, COMMENTS ON THE NOMINATION OF SHLOMO YANAI TO THE PDL BOARD OF DIRECTORS AND DELIVERS LETTER TO THE BOARD OUTLINING SIGNIFICANT CONCERNS

* SEVENSAOI’S LETTER TO BOARD OF PDL BIOPHARMA DETAILS 3 MAIN AREAS OF CONCERN, LIKE POOR CAPITAL ALLOCATION, ACQUISITION PRACTICES

* SAYS OWNS 2.6 MILLION SHARES OF COMMON STOCK OF PDL BIOPHARMA Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below